In spite of these scientific advances, clinical determination of steatohepatitis continues to rely on liver histology. Biopsy evaluation continues to play a central role in clinical trials as well.

Non-alcoholic steatohepatitis (NASH) is a condition characterized by accumulation of fat, inflammation and injury in liver cells in people who consume little or no alcohol. It is the progressive ...

Nonalcoholic steatohepatitis (NASH ... and focus on current discussions related to the specific lesions in the pathology of NASH, including the challenges of pediatric NASH and NASH-related ...

Metabolic Dysfunction-Associated Steatohepatitis [MASH] is a type ... expected to be released in the 1st half of 2026. There is a histology biomarker study that is also exploring the use of ...